Sign in
Download Opera News App

COVID

 

Society COVID

 

USA Company Begins COVID-19 Vaccine Trial In South Africa

An American company Novavax is currently working on the development of the COVID-19 vaccine. Novavax reported that it has started with a Phase 2b clinical trial in South Africa to assess the effectiveness of a Covid-19 vaccine in a volunteer.





Dr Shabir Madhi, a professor of Vaccinology at the Witswatersrand University, will be leading the clinical trials that are partly supported by a $15 million donation from the Bill & Melinda Gates Foundation, the Novavax said in a realesed statement on Monday 17th of August 2020.

The American company, Novavax also mentioned that the vacinne trial will be made up of two units

The first batch will examine the success rate, safety and immunogenicity in approximately 2,665 healthy South African adults.

The second batch is meant to assess the safety and immunogenicity in close to 240 medically stable and HIV-positive adults.

This will allow the assessment of the trail vaccine to be tested over a diverse, representative study group population.

Novavax said it expects that, if the trail COVID-19 vaccine is officially approved in South Africa, their Covid-19 vaccine will be disbursed to South Africa in the long run through a partnership with the Serum Institute of India.

Content created and supplied by: LifestyleZA (via Opera News )

COVID-19 Melinda Gates Foundation Novavax Shabir Madhi USA

COMMENTS

Load app to read more comments